Maged1 is a transcriptional co-activator that has been implicated in the regulation of myogenic differentiation [30], sexual behavior [31], obesity [31] and the transcriptional function of Dlx5[32], a positive regulator of osteoblast differentiation and bone mass [33], [34]. Here, DLX5 is linked to obesity disorder.